Takara Bio Inc
TSE:4974
Takara Bio Inc
Cash from Operating Activities
Takara Bio Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Takara Bio Inc
TSE:4974
|
Cash from Operating Activities
¥24.1B
|
CAGR 3-Years
36%
|
CAGR 5-Years
26%
|
CAGR 10-Years
27%
|
|
GNI Group Ltd
TSE:2160
|
Cash from Operating Activities
¥6.5B
|
CAGR 3-Years
68%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
PeptiDream Inc
TSE:4587
|
Cash from Operating Activities
¥12.4B
|
CAGR 3-Years
93%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Cash from Operating Activities
¥6.1B
|
CAGR 3-Years
76%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Cash from Operating Activities
-¥138.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
6%
|
CAGR 10-Years
17%
|
S
|
StemRIM Inc
TSE:4599
|
Cash from Operating Activities
¥1.1B
|
CAGR 3-Years
25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Takara Bio Inc's Cash from Operating Activities?
Cash from Operating Activities
24.1B
JPY
Based on the financial report for Dec 31, 2023, Takara Bio Inc's Cash from Operating Activities amounts to 24.1B JPY.
What is Takara Bio Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
27%
Over the last year, the Cash from Operating Activities growth was 398%. The average annual Cash from Operating Activities growth rates for Takara Bio Inc have been 36% over the past three years , 26% over the past five years , and 27% over the past ten years .